Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
Linus Torvalds announced the release of third release candidate (RC3) for the upcoming Linux Kernel version 6.18. Here's what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback